Showing 1 - 10 of 10
The aim of this paper is to assess whether cost-containment has been affected by recent pharmaceutical reimbursement reforms that have been introduced in the Spanish health care system over the period 1996-2002, under the conservative Popular Party government. Four main reimbursement policies...
Persistent link: https://www.econbiz.de/10005704975
This paper studies oligopolistic competition in off-patent pharmaceutical markets using a vertical product differentiation model. This model can explain the observation that countries with stronger regulations have smaller generic market shares. It can also explain the differences in observed...
Persistent link: https://www.econbiz.de/10005827428
The aim of this paper is to assess whether cost-containment has been affected by recent pharmaceutical reimbursement reforms that have been introduced in the Spanish health care system over the period 1996-2002, under the conservative Popular Party government. Four main reimbursement policies...
Persistent link: https://www.econbiz.de/10005771934
The aim of this paper is to analyse empirically entry decisions by generic firms into markets with tough regulation. Generic drugs might be a key driver of competition and cost containment in pharmaceutical markets. The dynamics of reforms of patents and pricing across drug markets in Spain are...
Persistent link: https://www.econbiz.de/10005771939
The aim of this paper is to analyse empirically entry decisions by generic firms into markets with tough regulation. Generic drugs might be a key driver of competition and cost containment in pharmaceutical markets. The dynamics of reforms of patents and pricing across drug markets in Spain are...
Persistent link: https://www.econbiz.de/10005772415
This paper studies oligopolistic competition in off-patent pharmaceutical markets using a vertical product differentiation model. This model can explain the observation that countries with stronger regulations have smaller generic market shares. It can also explain the differences in observed...
Persistent link: https://www.econbiz.de/10005772420
This paper provides empirical evidence on the explanatory factors affecting introductory prices of new pharmaceuticals …
Persistent link: https://www.econbiz.de/10010553343
It is commonly argued that in recent years pharmaceutical companies have directed their R&D towards small improvements of existing compounds instead of more risky drastic innovations. In this paper we show that the proliferation of these small innovations is likely to be linked to the lack of...
Persistent link: https://www.econbiz.de/10005772335
I show that an advertising ban is more likely to increase -- rather than decrease -- total consumption when advertising … allowing firms to command higher prices). In this case, the main impact of a ban on advertising is to reduce equilibrium prices …--ante (i.e. without advertising) similar and advertising is of the `persuasive' type. The ban is the more likely to increase …
Persistent link: https://www.econbiz.de/10005772016
sufficiently reduces advertiser profits. Newspaper competition generally reduces the impact of advertising. In fact, as the size of … advertising grows, newspapers may paradoxically reduce advertiser bias, due to increasing competition for readers. However …
Persistent link: https://www.econbiz.de/10005572642